Commentary on the next two abstracts follows the second abstract. Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan. Nelson JB, Nabulsi AA, Vogelzang NJ, Breul J, Zonnenberg BA, Daliani DD, Schulman CC, Carducci MA, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD: J Urol 2003;169:1143–1149

✍ Scribed by Donald L. Trump

• Book ID: 117724322
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 14 KB
• Volume: 21
• Category: Article
• ISSN: 1078-1439
• DOI: 10.1016/s1078-1439(03)00110-8